BioSpace News Archive

Enzychem Lifesciences (KOSDAQ: 183490), announced today that it has completed patient enrollment in Stage 2 of its Phase 2 clinical trial of EC-18 in chemoradiation induced oral mucositis (CRIOM).

HUYABIO International (HUYABIO™), the leader in accelerating global development of China’s pharmaceutical innovations, today announced the submission of a regulatory application to the Japanese Pharmaceuticals and Medical Devices Agency for HBI-8000 monotherapy for relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL).

Today, Diagnostic Robotics and Blue Cross & Blue Shield of Rhode Island (BCBSRI) announced a partnership to bring the full capabilities of artificial intelligence to members living with certain chronic conditions.

In addition to smoothing out wrinkles, researchers have found that the drug Botox can reveal the inner workings of the brain.

The U.S. Food and Drug Administration today announced it has issued an emergency use authorization (EUA) for the Symbiotica COVID-19 Self-Collected Antibody Test System, the first antibody test authorized for use with home collected dried blood spot samples.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) is pleased to announce awards to three collaborative Certified Duchenne Care Center (CDCC) network projects totaling $450,000.

Stanford Children’s Health once again is ranked as a national leader for pediatric organ transplantation, according to recent data from the Scientific Registry of Transplant Recipients.

The Ardonagh Group and Amynta Group today announce that they have acquired AccuRisk Holdings LLC, a Chicago-based managing general underwriter specialising in medical stop loss, occupational accident and supplemental health products for small and mid-sized businesses

On March 31, 2021, the Company, through its relationship with Brookstone Partners, executed definitive documents and acquired a minority interest in a consumer products company, Diamond Products, LLC, a sexual wellness holding company.

This Grant will Fund the Completion of the Company’s Pre-Clinical Research Paving the Way to Initiate a Clinical Study for this Indication.